<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Kyowa Kirin</title>
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="format-detection" content="telephone=no">
<meta name="description" content="The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.">
<meta property="og:title" content="Kyowa Kirin">
<meta property="og:description" content="The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.">
<meta property="og:image" content="/share/images/img_ogp.png">
<meta property="og:type" content="website">
<link rel="shortcut icon" href="/share/images/favicon.ico">
<link rel="apple-touch-icon" href="/share/images/apple_touch_icon.png">
<link rel="stylesheet" href="/share/css/outBoundModal.css">
<link rel="stylesheet" href="/share/css/common.css">
<link rel="stylesheet" href="/share/css/kkc-animation.css">
<link rel="canonical" href="/index.html">
<script src="/share/js/init.js"></script>
<script async src="https://www.kyowakirin.co.jp//share/js/settrack.js" defer></script>
<style>
  .box-movie-thumb {
    line-height: 1.5;
  }
</style>
</head>
<body>
<!-- ======================== Header START =================================== -->
<header class="header">
<div class="header-inner">
<div class="logo"><a href="/index.html"><img src="/share/images/logo.png" alt="KYOWA KIRIN"><img src="/share/images/logo-kkap.png" alt="Kyowa Kirin Asia Pacific Pte. Ltd."></a></div>
<nav class="header-nav">

<ul class="header-nav-list header-menu">
<li><a href="/index.html">Home</a>
<div class="header-menu-inner">
<ul class="header-list-global">
<li><a href="/index.html#anc-our-vision">Our vision</a></li>
<li><a href="/index.html#anc-our-philosophy">Our philosophy</a></li>
<li><a href="/index.html#anc-core-values">Core values</a></li>
<li><a href="/index.html#anc-at-a-glance">At a glance</a></li>
<li><a href="/index.html#anc-kkap-in-numbers">In numbers</a></li>
<li><a href="/index.html#anc-global-network">Asia Pacific network</a></li>
<li><a href="/index.html#anc-careers">Life at KKAP</a></li>
<!-- /.header-list-global --></ul>

<!-- /.header-menu-inner --></div>
</li>
<li><a href="/who_we_are/index.html">Who we are</a>
<div class="header-menu-inner">
<ul class="header-list-global">
<li><a href="/who_we_are/index.html#anc-areas-of-focus">Areas of focus</a></li>
<li><a href="/who_we_are/index.html#anc-technology-driven-drug-discovery">Technology-driven drug discovery</a></li>
<li><a href="/who_we_are/index.html#anc-main-products">Our products</a></li>
<li><a href="/who_we_are/index.html#anc-partnerships">Partnerships</a></li>
<!-- /.header-list-global --></ul>

<!-- /.header-menu-inner --></div>
</li>
<li><a href="/our_medicines/index.html">Our medicines</a></li>
<li><a href="https://www.kyowakirin.com/media_center/index.html" target="_blank">News</a></li>
<li><a href="/working_with_us/index.html">Working with us</a></li>
<li>
<div class="box-input-search">
<form name="search_form" action="https://search.kirin.dga.jp/kkc_en/" method="GET" onsubmit="return mysearch_kirin(this,'kkc_en');">
<button type="button" class="header-btn-search"><img src="/share/images/icon_search_01.png" alt="open search area"></button>
<input type="text" name="kw" value="" title="Search" class="iSearchAssist header-input-search searchBox" autocomplete="off">
<input type="hidden" name="ie" value="u">
<input type="submit" class="header-btn-search-submit" value="Search">
<button type="button" class="header-btn-delete"><img src="/share/images/icon_close_02.png" alt="close search area"></button>
</form>

<!-- /.box-input-search --></div>
</li>
<!-- /.header-list --></ul>

<ul class="header-nav-list header-search">
<li class="header-link-contact"><a href="https://www.kyowakirin.com/contact_us/index.html" target="_blank"><img src="/share/images/icon_contact_01.png" alt="move to contact_us page"></a></li>
<li>
<button type="button" class="btn-menu-global">open menu</button>
<div class="menu-global-wrapper">
<h2 class="menu-global-hdg-lv2">Kyowa Kirin Worldwide</h2>
<div class="menu-global-inner">

<div class="box-list-link">
<h3 class="menu-global-hdg-lv3">JAPAN<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin Co., Ltd. ( <a href="https://www.kyowakirin.co.jp/index.html" class="text-link-sub" target="_blank">日本語</a> )</li>
<li>Kyowa Medical Promotion Co., Ltd.</li>
<li>Kyowa Media Service Co., Ltd.</li>
<li>Kyowa Iryo Kaihatsu Co., Ltd.</li>
<li>FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. ( <a href="http://fujifilmkyowakirin-biologics.com/ja/index.html" class="text-link-sub" target="_blank">日本語</a> / <a href="http://fujifilmkyowakirin-biologics.com/en/index.html" class="text-link-sub" target="_blank">English</a> )</li>
<li>Kyowa Kirin plus Co., Ltd. ( <a href="http://www.kyowakirinplus.co.jp/" class="text-link-sub" target="_blank">日本語</a> )</li>
<li>Kyowa Kirin Frontier Co., Ltd. ( <a href="https://www.kyowa-kirin-frontier.com/" class="text-link-sub" target="_blank">日本語</a> )</li>
</ul>

<h3 class="menu-global-hdg-lv3">NORTH AMERICA<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin USA Holdings, Inc.  ( <a href="#outBoundModal-exception-03" class="text-link-sub">English</a> )</li>
<li>BioWa, Inc.  ( <a href="https://www.kyowakirin.com//biowa/index.html" class="text-link-sub" target="_blank">English</a> )</li>
<li>Kyowa Kirin Pharmaceutical Development, Inc.  ( <a href="https://www.kyowakirin.com//kkd/index.html" target="_blank" class="text-link-sub">English</a> )</li>
<li>Kyowa Kirin Pharmaceutical Research, Inc.  ( <a href="https://www.kyowakirin.com//kkr/index.html" target="_blank" class="text-link-sub">English</a> )</li>
<li>Kyowa Kirin, Inc.  ( <a href="http://www.international.kyowa-kirin.com/usa/index.html" target="_blank" class="text-link-sub">English</a> )</li>
</ul>
<!-- /.box-list-link --></div>

<div class="box-list-link">
<h3 class="menu-global-hdg-lv3">ASIA<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin Asia Pacific Pte. Ltd.  ( <a href="https://www.kyowakirin.com/singapore/index.html" class="text-link-sub" target="_blank">English</a> )</li>
<li>Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. ( <a href="http://www.kyowa-kirin.com.cn/index.html" class="text-link-sub" target="_blank">中文</a> )</li>
<li>Kyowa Kirin Korea Co., Ltd.  ( <a href="https://www.kyowakirin.com/kr/index.html" class="text-link-sub" target="_blank">한국어</a> )</li>
<li>Kyowa Kirin Taiwan Co., Ltd.  ( <a href="https://www.kyowakirin.com/tw/index.html" class="text-link-sub" target="_blank">中文</a> )</li>
<li>Kyowa Kirin Hong Kong Co., Limited  ( <a href="https://www.kyowakirin.com/hk/cn/index.html" class="text-link-sub" target="_blank">中文</a> / <a href="https://www.kyowakirin.com/hk/index.html" class="text-link-sub" target="_blank">English</a> )</li>
<li>Kyowa Kirin (Thailand) Co., Ltd. ( <a href="https://www.kyowakirin.com/thailand/index.html" class="text-link-sub" target="_blank">ภาษาไทย</a> )</li>
</ul>
<!-- /.box-list-link --></div>

<div class="box-list-link">
<h3 class="menu-global-hdg-lv3">EUROPE<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin International plc  ( <a href="http://www.international.kyowa-kirin.com/index.html" class="text-link-sub" target="_blank">English</a> )</li>
<li>Kyowa Kirin Ltd.  ( <a href="http://www.international.kyowa-kirin.com/uk/index.html" class="text-link-sub" target="_blank">English</a> )</li>
<li>Kyowa Kirin Pharma SAS ( <a href="#outBoundModal-exception-02" class="text-link-sub">France</a> )</li>
<li>Kyowa Kirin Farmaceutica, S.L.U.  ( <a href="http://www.international.kyowa-kirin.com/es/index.html" class="text-link-sub" target="_blank">Español</a> )</li>
<li>Kyowa Kirin GmbH  ( <a href="http://www.international.kyowa-kirin.com/de/index.html" class="text-link-sub" target="_blank">Deutsch</a> )</li>
<li>Kyowa Kirin Pharma B.V. - Netherlands  ( <a href="http://www.international.kyowa-kirin.com/nl/index.html" class="text-link-sub" target="_blank">Nederlands</a> )</li>
<li>Kyowa Kirin Pharma B.V. - Belgium &amp; Luxembourg  ( <a href="http://international.kyowa-kirin.com/belux/index.html" class="text-link-sub" target="_blank">English</a> )</li>
<li>Kyowa Kirin S.r.l.  - Italia ( <a href="http://www.international.kyowa-kirin.com/it/index.html" class="text-link-sub" target="_blank">Italiano</a> )</li>
<li>Kyowa Kirin AB - Sweden  ( <a href="http://www.international.kyowa-kirin.com/se/index.html" class="text-link-sub" target="_blank">Svenska</a> )</li>
<li>Kyowa Kirin AB - Norway  ( <a href="http://www.international.kyowa-kirin.com/no/index.html" class="text-link-sub" target="_blank">Norsk</a> )</li>
<li>Kyowa Kirin AB - Finland  ( <a href="http://www.international.kyowa-kirin.com/fi/index.html" class="text-link-sub" target="_blank">Suomalainen</a> )</li>
<li>Kyowa Kirin AB - Denmark  ( <a href="http://www.international.kyowa-kirin.com/dk/index.html" class="text-link-sub" target="_blank">Dansk</a> )</li>
</ul>
<!-- /.box-list-link --></div>

<!-- /.menu-global-inner --></div>
<!-- /.menu-global-wrapper --></div>
</li>
<li>
<button type="button" class="btn-sp-menu"><img src="/share/images/icon_menu_sp_01.png" alt="open menu"></button>
</li>
<!-- /.header-list --></ul>

<ul class="header-nav-list header-menu-sp">
<li>
<div class="box-input-search">
<form name="search_form" action="https://search.kirin.dga.jp/kkc_en/" method="GET" onsubmit="return mysearch_kirin(this,'kkc_en');">
<button type="button" class="header-btn-search"><img src="/share/images/icon_search_03.png" alt="open search area"></button>
<input type="text" name="kw" value="" title="Search" class="iSearchAssist header-input-search searchBox" autocomplete="off">
<input type="hidden" name="ie" value="u">
<input type="submit" class="header-btn-search-submit" value="Search">
<button type="button" class="header-btn-delete"><img src="/share/images/icon_close_03.png" alt="close search area"></button>
</form>

<!-- /.box-input-search --></div>
</li>
<li><button type="button" class="btn-header-menu-sp-toggle">Who we are<span>open</span></button>
<div class="header-menu-sp-toggle">
<a href="/index.html">Who we are TOP</a>
<ul class="header-menu-sp-list">
  <li><a href="/index.html#anc-our-vision">Our vision</a></li>
  <li><a href="/index.html#anc-our-philosophy">Our philosophy</a></li>
  <li><a href="/index.html#anc-core-values">Core values</a></li>
  <li><a href="/index.html#anc-at-a-glance">At a glance</a></li>
  <li><a href="/index.html#anc-kkap-in-numbers">In numbers</a></li>
  <li><a href="/index.html#anc-global-network">Asia Pacific network</a></li>
  <li><a href="/index.html#anc-careers">Life at KKAP</a></li>
</ul>
<!-- /.header-menu-sp-list --></div>
</li>
<li><button type="button" class="btn-header-menu-sp-toggle">What we do<span>open</span></button>
<div class="header-menu-sp-toggle">
<a href="/who_we_are/index.html">What we do TOP</a>
<ul class="header-menu-sp-list">
  <li><a href="/who_we_are/index.html#anc-areas-of-focus">Areas of focus</a></li>
  <li><a href="/who_we_are/index.html#anc-technology-driven-drug-discovery">Technology-driven drug discovery</a></li>
  <li><a href="/who_we_are/index.html#anc-main-products">Our products</a></li>
  <li><a href="/who_we_are/index.html#anc-partnerships">Partnerships</a></li>
</ul>
<!-- /.header-menu-sp-list --></div>
</li>
<li><a href="https://www.kyowakirin.com/sustainability/index.html" target="_blank">Sustainability</a></li>
<li><a href="https://www.kyowakirin.com/media_center/index.html" target="_blank">News</a></li>
<li><a href="/working_with_us/index.html">Working with us</a></li>
<!-- /.header-list --></ul>

<!-- /.header-nav --></nav>
<!-- /.header-inner --></div>
</header>
<!-- ======================== Header END =================================== -->

<main>
<!-- ======================== Main Content START =================================== -->
<div class="wrapper">


<div class="box-hdg-wrapper type-04 kkc-anime_load_other-mainvisual our-medicines-header">
<div class="image">
<img src="/images/index_bg_mainsection_01.png" alt="">
  <!-- /.image --></div>
<!-- /.image --></div>

<div class="str-section-wrapper first-section our-medicines-01">
<div class="str-section str-section-boxed">
<div class="box-hdg2-wrapper" id="our-medicines">
<h1 class="hdg-lv2-02">Our Medicines</h1>
<p class="text-lead">Kyowa Kirin has an advanced research and development system that displays innovation in drug discovery using cutting-edge biotechnology in antibody engineering technology.</p>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>4
<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper whatwedo-01">
<div class="str-section">
<div class="box-hdg2-wrapper" id="anc-areas-of-focus">
<h2 class="hdg-lv2-03">Our Therapeutic area </h2>
<div class="box-text text-center"> We use this technology across the four therapeutic areas of: nephrology, oncology, central nervous system and immunology and allergy.</div>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>

<div class="area-focus-wrapper">
<div class="area-focus-inner">
<p class="title">Cutting-edge biotechnology<br> centered on antibody<br> engineering technology</p>
<!-- /.area-focus-inner --></div>
<div class="area-focus-icon icon-01 kkc-anime_scroll_focus-icon_trigger kkc-anime_trigger_focus-icon_item kkc-anime_state_show kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger="focus-icon1" data-trigger-name="focus-icon1">
<img src="/who_we_are/images/index_img_parts_01.png" class="sp-hide" alt="Nephrology">
<img src="/who_we_are/images/index_img_parts_01_sp.png" class="pc-hide" alt="Nephrology">
</div>
<div class="area-focus-icon icon-02 kkc-anime_trigger_focus-icon_item kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger-name="focus-icon1">
<img src="/who_we_are/images/index_img_parts_02.png" class="sp-hide" alt="Immunology &amp; Allergy">
<img src="/who_we_are/images/index_img_parts_02_sp.png" class="pc-hide" alt="Immunology &amp; Allergy">
</div>
<div class="area-focus-icon icon-03 kkc-anime_scroll_focus-icon_trigger kkc-anime_trigger_focus-icon_item kkc-anime_state_show kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger="focus-icon2" data-trigger-name="focus-icon2">
<img src="/who_we_are/images/index_img_parts_03.png" class="sp-hide" alt="Oncology">
<img src="/who_we_are/images/index_img_parts_03_sp.png" class="pc-hide" alt="Oncology">
</div>
<div class="area-focus-icon icon-04 kkc-anime_trigger_focus-icon_item kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger-name="focus-icon2">
<img src="/who_we_are/images/index_img_parts_04.png" class="sp-hide" alt="Central Nervous System">
<img src="/who_we_are/images/index_img_parts_04_sp.png" class="pc-hide" alt="Central Nervous System">
</div>
<!-- /.area-focus-wrapper --></div>

<!-- /.str-section-wrapper --></div>


<div class="str-section-wrapper str-section-blue-bg our-medicines-03 ">
<div class="str-section str-section-boxed str-section-spacing">
<div class="box-hdg2-wrapper" id="technology-driven-drug-discovery">
<h2 class="hdg-lv2-04">Technology-driven drug<br> discovery</h2>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>4
<!-- /.str-section-wrapper --></div>


<div class="str-section-wrapper our-medicines-04">
<div class="str-section str-section-boxed str-section-spacing">
<div class="box-hdg2-wrapper">
<p class="text-lead">The novel drug discovery of Kyowa Kirin is firmly supported by the exquisite experience and technologies in research, development and manufacture of biologics, and by open innovation. </p>
<br>
<div class="box-text text-center">
We endeavor to move forward with the four modalities consisting of therapeutic antibodies, small molecule drugs, nucleic acid drugs and regenerative medicine. This unique style of drug discovery is what we call technology-driven drug discovery.
We define modality as the classification of drug discovery technologies to realize the therapeutic concepts that we conceive of.</div>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>
<!-- /.str-section-wrapper --></div>


<div class="str-section-wrapper our-medicines-05">
<div class="str-section str-section-boxed-800px str-section-spacing">
<div class="box-hdg2-wrapper">
  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">Next Generation Therapeutic Antibodies</h3>
  <div class="box-text">
  <p>The distinguished fundamental technologies of Kyowa Kirin are characterized by POTELLIGENT® and human-antibody producing mice (human artificial chromosome vector) technologies which we successfully established, and contribute to efficient production of therapeutic antibodies.</p>
  <p>Making the most of our knowledge and experience in protein and antibody engineering technology as well as in control of glycosylation, we are engaged in research and development of next generation therapeutic antibodies e.g., immune-activating antibodies and tissue-homing antibodies in collaboration with external research institutes.
</p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_01.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">New Type of Small Molecule Drugs</h3>
  <div class="box-text">
  <p>Our approach to small molecule drug discovery involves rational drug design, i.e., structure-based drug design (SBDD) ranging from the structural analysis of disease-associated biomolecules (therapeutic target) to the design of small molecules.</p>
  <p>In pursuit of effective process from drug target hunting and seed discovery through producing drug candidates, we utilize phenotypic assay for disease state model, chemical biology, and bio- and chemo-informatics. In addition, we have initiated research in combining chemistry and biologics.</p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_02.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">Nucleic Acid Drugs</h3>
  <div class="box-text">
  <p>We are actively working on development of nucleic acid drugs which attract attention as new therapy. Unique technologies focusing on lipid nanoparticles have successfully established as a result of challenge to construction of drug delivery system that is indispensable for nucleic acid drugs. Technology research on enhancement of nucleic acid function has also been initiated at our research laboratories. We proactively challenge collaboration researches on drug target discoveries and new technologies.</p>
  <p>Our goal through these activities is to create and deliver innovative medicines for the drug targets for which effective treatment approach cannot be established with therapeutic antibodies or low molecular drugs.</p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_03.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">Regenerative Medicine</h3>
  <div class="box-text">
  <p>To broaden our major research and development areas, we embarked on the challenge to regenerative medicine as the fourth modality following small molecule drugs, therapeutic antibodies, and nucleic acid drugs. Based on our knowledge and experience in genetic engineering as well as in cell analysis, our research extends to utilize the novel and multiplex potentials of cells.</p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_04.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>4
<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper str-section-blue-bg our-medicines-06 ">
<div class="str-section str-section-boxed str-section-spacing">
<div class="box-hdg2-wrapper" id="technology-driven-drug-discovery">
<h2 class="hdg-lv2-04">Our Medicines</h2>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>4
<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper our-medicines-07">
<div class="str-section str-section-boxed str-section-spacing">
<div class="box-hdg2-wrapper">
<div class="box-text text-center">At Kyowa Kirin, we strive to develop effective therapies for our patients within our areas of focus. We combine a unique balance between technology and innovation into our drug development and discovery. Our dedicated team of experts make important strides in understanding the patient needs in the areas of nephrology, oncology, haematology and central nervous system.</div>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>
<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper our-medicines-08">
<div class="str-section str-section-boxed-800px str-section-spacing">
<div class="box-hdg2-wrapper">


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">CRYSVITA®</h3>
  <div class="box-text">
  <p>CRYSVITA®  (burosumab) is a recombinant fully human monoclonal lgG1 antibody against the phosphaturic hormone fibroblast growth factor 23 (FGF23). By locking excess FGF23 in patients, CRYSVITA® is intended to increase phosphate reabsorption in the kidney and increase the production of vitamin D, which enhances intestinal absorption of phosphate and calcium in patients with X linked hypophosphatemia.</p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_slide_crysvita.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">POTELIGIO®</h3>
  <div class="box-text">
  <p>POTELIGIO® (mogamulizumab-kpkc) is a humanised monoclonal antibody that targets CC chemokine receptor 4 (CCR4), which is frequently expressed on leukemic cells of certain hematologic malignancies including cutaneous T-cell lymphomas (CTCL), such as mycosis fungoides and Sezary syndrome.</p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_slide_poteligeo.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">NESP®</h3>
  <div class="box-text">
  <p>NESP®  (darbepoetin alfa) is an erythropoiesis stimulating agent (ESA) with longer-lasting effect than conventional erythropoietin drugs. It is effective for improving renal anaemia with reduced administration frequency. </p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_slide_espo.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">REGPARA®</h3>
  <div class="box-text">
  <p>REGPARA® (cinacalcet) is a new class of agent for the treatment of secondary hyperparathyroidism. REGPARA acts on parathyroid calcium receptor directly and suppresser parathyroid hormone secretion, while simultaneously lowering serum calcium and phosphorus levels. </p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_slide_regpara.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">Romiplate®</h3>
  <div class="box-text">
  <p>Romiplate®, (romiplostim) a genetically recombinant protein, stimulates platelet production via stimulation of the thrombopoietin receptors. </p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_slide_romiplate.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


  <div class="box-layout-image layout-left box-layout-image-post-list">
  <div class="box-content">
  <h3 class="hdg-lv2-05">GRAN®</h3>
  <div class="box-text">
  <p>Disclaimer: Please check on the availability and the approved indications of the products in your markets</p>
  <!-- /.box-text --></div>
  <!-- content --></div>
  <div class="box-image">
  <img src="images/index_img_slide_gran.jpg" alt="">
  <!-- image --></div>
  <!-- /.box-layout-image --></div>


<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>4
<!-- /.str-section-wrapper --></div>


<!-- /.wrapper --></div>
<!-- ======================== Main Content END =================================== -->
</main>

<!-- ======================== Footer START =================================== -->
<footer class="footer">
<div class="logo"><a href="/index-2.html"><img src="/share/images/logo_footer.png" alt="KYOWA KIRIN"></a></div>
<div class="footer-inner">

<ul class="footer-link">
<li><a href="/index.html">Who we are</a></li>
<li><a href="/what_we_do/index.html"><span class="sp-hide">Research & Development</span><span class="pc-hide">R & D</span></a></li>
<li><a href="https://www.kyowakirin.com/contact_us/index.html" target="_blank">Contact us</a></li>
<li><a href="/what_we_do/index.html">What we do</a></li>
<li><a href="https://www.kyowakirin.com/sustainability/index.html" target="_blank">Sustainability</a></li>
<li><a href="https://www.kyowakirin.com/index.html" target="_blank">Kyowa Kirin Group</a></li>
<li><a href="/working_with_us/index.html">Working with us</a></li>
<li><a href="https://www.kyowakirin.com/media_center/index.html" target="_blank">News</a></li>
<li><a href="/privacy_policy/index.html" target="_blank">Privacy Policy</a></li>
<li><a href="/working_with_us/index.html#anc-join-us">Join us</a></li>
<li><a href="/terms_and_conditions/index.html">Terms & Conditions</a></li>

</ul>

<div class="footer-area-sub">
<!-- <ul class="footer-link-sns">
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_twitter.png" alt="twitter"></a></li>
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_facebook.png" alt="facebook"></a></li>
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_linkedin.png" alt="linkedin"></a></li>
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_google.png" alt="google"></a></li>
</ul> -->
<a href="#top" id="back-to-top-button"><span>BACK TO TOP</span></a>
<p class="footer-copy"><small>Copyright © Kyowa Kirin Co., Ltd.   All rights reserved.</small></p>
<!-- /.footer-area-sub --></div>

<!-- /.footer-inner --></div>
</footer>
<!-- ======================== Footer END =================================== -->

<!-- ======================== Cookie Notice START =================================== -->
<div class="box-cookie-notice">
<div class="box-inner">
  <div class="box-text">
  <center><p>We use cookie to improve your experience on our website. <a href="javascript:void(0)" id="cookie-notice-ok" class="btn-01 btn-small">OK</a></p></center>
  <!-- /.box-text --></div>
<!-- /.box-inner --></div>
<!-- /.cookie-notice-wrapper --></div>
<!-- ======================== Cookie Notice END =================================== -->

<script src="/share/js/jquery-3.3.1.min.js"></script>
<script src="/share/js/outBoundModal.js" charset="UTF-8"></script>
<script src="/share/js/run.js"></script>
<script src="/share/js/search.js" defer></script>
<script src="/share/js/kkc-animation.js" defer></script>
<script src="/share/js/cookie-notice.js" defer></script>
<script src="/share/js/back-to-top-button.js" defer></script>
</body>
</html>

